Aster DM Quality Care Reports 19% Revenue Growth and Capacity Expansion in Q2 FY27
First full quarter post-merger shows highest revenue and EBITDA, with plans to add 4,230 beds and expand advanced clinical services
Aster DM Quality Care Limited announced its Q2 and H1 FY27 earnings conference call transcript highlighting a 19% year-on-year revenue increase to INR 2,829 crore, a 25% rise in operating EBITDA, and a 34% growth in normalized profit after tax. The company marked its first full quarter post-merger with advanced clinical capabilities and announced plans to expand capacity by over 4,000 beds, reaching 15,000 beds. Key developments include new Centres of Excellence and significant growth in complex care procedures like robotic surgeries and transplants.
Aster DM Quality Care Limited
Earnings Call Transcript
Aster DM Quality Care Limited announced its financial and operational results for the quarter and half-year ended September 30, 2026, reporting its strongest performance since the merger and outlining significant capacity expansion plans.
In Q2 FY27, Aster DM Quality Care achieved consolidated revenue of INR 2,829 crore, increasing 19% year-on-year, and operating EBITDA growth of 25%. Normalized profit after tax rose 34% compared to the same period last year.
The company marked its first full quarter after merging Aster DM Healthcare and Quality Care, focusing on integrating operations and expanding clinical expertise through Centres of Excellence such as the ARISE Robotic Spine Institute, CARE Cancer Institute in Raipur, and Foetal Medicine Centre at Aster Medcity.
Operational bed base grew 4% year-on-year, with occupancy rising by 335 basis points to 68%, reflecting better utilisation. The hospital network treated 2.2 million patients in Q2 FY27, a 12% increase from the prior year, with more patients seeking complex treatments.
Advanced clinical procedures demonstrated significant growth: robotic surgeries increased by 39%, kidney transplants by 31%, joint replacements by 29%. The network introduced pioneering treatments in regional hospitals, including district-first mechanical thrombectomy and stroke units.
Aster DM Quality Care plans to expand total hospital capacity to over 15,000 beds, adding 4,230 beds. Investments exceeding INR 600 crore support capacity expansion and clinical capabilities to reach more patients, especially in Tier 2 and Tier 3 cities.
Highlights
- Revenue grew 19% year-on-year to INR 2,829 crore in Q2 FY27.
- Operating EBITDA increased 25%, normalized profit after tax rose 34%.
- Treated 2.2 million patients in Q2 FY27—12% growth year-on-year.
- Operational bed base expanded by 4%, occupancy improved to 68%.
- Robotic surgeries up 39%, kidney transplants up 31%, joint replacements up 29%.
- Launched new Centres of Excellence including ARISE Robotic Spine Institute and CARE Cancer Institute in Raipur; Foetal Medicine Centre at Aster Medcity added this quarter as well.|Announced plan for 4,230 new beds, ramping capacity from 10,
Key Data Snapshot
What happened
- Aster DM Quality Care reported Q2 and H1 FY27 earnings, marking its first full quarter following the merger of Aster DM Healthcare and Quality Care.
- The company achieved its highest-ever revenue and operating EBITDA, with substantial year-on-year growth in revenue, EBITDA, and profit after tax.
- Patient volumes increased by 12% year-on-year, with more patients requiring complex care treatments across the hospital network.
Operational performance
- Operational bed capacity expanded by 4%, with occupancy improving by 3.35 percentage points to 68%.
- There was strong growth in complex medical procedures including robotic surgeries (+39%), kidney transplants (+31%), and joint replacements (+29%).
- New Centres of Excellence launched, notably the ARISE Robotic Spine Institute, CARE Cancer Institute in Raipur, and the Foetal Medicine Centre at Aster Medcity, enhancing specialized care delivery.
- Regional hospitals introduced advanced procedures such as mechanical thrombectomy and established stroke units, expanding access to complex treatments beyond metropolitan areas.
Strategic context
- Since the merger announcement in November 2024, Aster DM Quality Care has integrated four healthcare brands to unify operations and clinical expertise.
- The company is focused on expanding capacity and upgrading clinical capabilities to provide quality healthcare in Tier 2 and Tier 3 cities.
- A planned bed capacity increase from 10,840 to over 15,000 beds positions the company for sustained growth and broader patient reach.
Next milestones
- Execution of the bed capacity expansion plan involving 4,230 additional beds.
- Continued enhancement of Centres of Excellence and scaling advanced clinical procedures across the network.
- Ongoing investments exceeding INR 600 crore to support expansion and clinical expertise development.
Highlights
- Revenue grew 19% year-on-year to INR 2,829 crore in Q2 FY27.
- Operating EBITDA increased 25%, normalized profit after tax rose 34%.
- Treated 2.2 million patients in Q2 FY27—12% growth year-on-year.
- Operational bed base expanded by 4%, occupancy improved to 68%.
- Robotic surgeries up 39%, kidney transplants up 31%, joint replacements up 29%.
- Launched new Centres of Excellence including ARISE Robotic Spine Institute and CARE Cancer Institute in Raipur; Foetal Medicine Centre at Aster Medcity added this quarter as well.|Announced plan for 4,230 new beds, ramping capacity from 10,
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on Earnings Call Transcript
View allLatest corporate announcements and market updates in Earnings Call Transcript.
Sunrakshakk Industries India Limited Posts INR 265.17 Crores Revenue with 130% PAT Increase in Q2 FY27
Sunrakshakk Industries India Limited reported its Q2 FY27 financial results with revenue of INR 265.17 crores and a profit after tax of INR 16 crores, reflecting year-on-year growth of 119.20% in revenue and 130.10% in PAT, supported by expansion in its FMCG, FMCG intermediates, and edible segments.
Read Full StoryReligare Enterprises Posts INR 4,717 Crores Income and INR 145 Crores Loss After Tax in H1 FY27, Resumes Lending and Strengthens Board
Religare Enterprises Limited has reported consolidated total income of INR 4,717 crores and a loss after tax of INR 145 crores for the half-year ending September 30, 2026, marking a 19% increase in income year-on-year. The company is transitioning from preparation to execution phase by strengthening its board with RBI-approved promoter and shareholder directors, resuming lending through Religare Finvest, and advancing growth in its core financial services and insurance businesses.
Read Full StoryBlack Box Limited Posts Record Q2 FY27 Revenue of INR 1,936 Crores and Expands Order Backlog to $1.04 Billion
Black Box Limited reported its highest-ever quarterly revenue of INR 1,936 crores for Q2 FY27, marking a 22% year-on-year increase, alongside an 88% year-on-year growth in its order backlog, which reached $1.04 billion as of September 2026. Data center order bookings crossed $250 million during H1 FY27, signaling strong momentum in hyperscale digital infrastructure projects.
Read Full Story